HCL helps Fortune 500 pharma & healthcare client mitigate risks, surge time-to-market | HCLTech

HCL helps Fortune 500 pharma & healthcare client mitigate risks, surge time-to-market

HCL helps Fortune 500 pharma & healthcare client mitigate risks, surge time-to-market

Client is a Fortune 500 British multinational pharmaceutical and healthcare company headquartered in Brentford, London with a portfolio of products for major Diseases.

The company has embarked upon implementation of a global financial and commercial core in SAP ECC 6.0 to simplify its operating model. A single, global SAP template using ECC 6.0 built upon the previous commercial ERP solution template with limited future customization has been deployed in successive waves.
 
HCLTech implemented the following using specific IPs, frameworks and accelerators. 
• Risk-based testing (RBT) is implemented using MoSCoW principles 
• Shift left approach implemented resulting in early testing and defect detection resulting shortened and effective test cycle time and corresponding accelerated time-to-market 
• HP QTP BPT accelerator is used to reduce test design effort